MedTrace Logo

High-dose Periop Statins for Prevention of DVT

NCT00259662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2016-12-01

No results posted yet for this study

Summary

This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce inflammatory responses and deep vein thrombosis formation when given in high doses in the perioperative period.

Conditions

  • Gynecologic Oncological Pelvic/Abdominal Surgery

Interventions

DRUG

atorvastatin

Sponsors & Collaborators

  • Washington Mutual Foundation

    collaborator UNKNOWN

  • Yale University

    lead OTHER

Principal Investigators

  • Ala S Haddadin, MD · Assistant Professor

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00259662 on ClinicalTrials.gov